PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
PLIANT THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.90−0.00 (-0.13%)
Close on Oct 19, 2026
- Market cap
- $55.65M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Dividends
Pliant Therapeutics has not reported a dividend
No dividend per share appears in Pliant Therapeutics's annual filings since fiscal 2018.